trans-4’-Hydroxy CCNU Lomustine-d4

• CAT Number: S000175
• Molecular Formula: C9H12D4ClN3O3
• Molecular Weight: 253.72
• Purity: ≥95%
• IUPAC Name: 1-(2-chloro-1,1,2,2-tetradeuterioethyl)-3-(4-hydroxycyclohexyl)-1-nitrosourea
• InChI: InChI=1S/C9H16ClN3O3/c10-5-6-13(12-16)9(15)11-7-1-3-8(14)4-2-7/h7-8,14H,1-6H2,(H,11,15)/i5D2,6D2
• InChIKey: BTNKSMIZKSHDNT-NZLXMSDQSA-N
• SMILES: [2H]C([2H])(C([2H])([2H])Cl)N(C(=O)NC1CCC(CC1)O)N=O

trans-4’-Hydroxy CCNU Lomustine-d4, a premium pharmaceutical research compound designed for advanced oncology and chemotherapeutic studies. As a deuterated analog of trans-4’-Hydroxy Lomustine (CCNU), it offers enhanced stability and improved pharmacokinetic properties. trans-4’-Hydroxy CCNU Lomustine-d4 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel cancer therapies. Trusted by leading laboratories, trans-4’-Hydroxy CCNU Lomustine-d4 is your go-to solution for cutting-edge cancer research. Unlock new possibilities in chemotherapy treatment with trans-4’-Hydroxy CCNU Lomustine-d4, where innovation meets reliability.

Reference

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.
[Content Brief]